Browse the evidence

Setmelanotide (MC4R agonist) is effective in reducing hunger and BMI in patients with HO due to hypothalamic injury, particularly those with specific genetic defects or structural damage affecting the melanocortin pathway.

Setmelanotide is a promising new treatment for HO that targets the root cause (MC4R deficiency). It requires daily injections and may cause skin darkening, but it is one of the few treatments showing efficacy in reducing BMI in this specific population.

Exogenous administration of undercarboxylated osteocalcin (ucOC) improves whole-body and skeletal muscle glucose metabolism and insulin sensitivity in animal models, though human evidence remains discordant.

Current research suggests that bone-derived factors like osteocalcin may help regulate blood sugar, especially in muscle. However, because human studies are inconsistent, there is no specific protocol to manipulate osteocalcin levels for diabetes treatment yet. Focus on proven methods: exercise (which naturally increases ucOC) and maintaining healthy bone density.

Sclerostin levels are elevated in individuals with Type 2 Diabetes and insulin resistance, and blocking sclerostin signaling improves insulin sensitivity in animal models.

High levels of sclerostin are linked to insulin resistance. While drugs targeting sclerostin (like romosozumab) exist for osteoporosis, their metabolic benefits are still being studied. For now, exercise and weight management remain the best ways to improve insulin sensitivity.

GLP-1 receptor agonists (specifically exenatide) reduce body fat and waist circumference in patients with hypothalamic obesity, with greater adiposity reduction observed in those with more extensive hypothalamic damage.

For patients with hypothalamic obesity, weekly exenatide injections (2 mg) can significantly reduce body fat and waist circumference, even if BMI changes are modest. This treatment is particularly effective for those with severe hypothalamic damage, likely because it works through brain pathways outside the damaged area. Side effects are mostly gastrointestinal.

Setmelanotide, a melanocortin-4 receptor (MC4R) agonist, reduces hunger and BMI in patients with hypothalamic obesity caused by acquired hypothalamic injury, marking a potential breakthrough for this condition.

Setmelanotide is an MC4R agonist that reduces hunger and BMI in patients with hypothalamic obesity. It is FDA-approved for genetic obesity and is showing effectiveness for acquired hypothalamic injury. A large Phase 3 trial is currently underway.

Skeletal muscle regeneration efficiency is time-of-day dependent, with injury occurring during the active phase (when satellite cell BMAL1 expression peaks) resulting in enhanced repair compared to injury during the inactive phase.

If you sustain a muscle injury or undergo strenuous exercise that causes damage, your body repairs the tissue more effectively during your active phase (typically daytime for humans). This is driven by satellite cell clocks peaking in activity (BMAL1) during this time. While you cannot control the injury, scheduling intense training sessions during your active phase may theoretically support faster or more robust repair compared to late-night sessions, though human data is still emerging.

The molecular clock component BMAL1 is required for satellite cell proliferation and the metabolic transition from oxidative to glycolytic energy sources during early muscle regeneration.

BMAL1 acts as a metabolic switch for muscle stem cells. When muscle is damaged, these cells must switch from resting energy (oxidative) to building energy (glycolytic) to multiply. BMAL1 regulates this switch. Disrupting your circadian rhythm (e.g., chronic shift work) might impair this metabolic flexibility, potentially slowing down the initial proliferation phase of muscle repair.

Cry2 is critical for the circadian regulation of myogenic differentiation and fusion by maintaining Cyclin D1 expression and Tmem176b rhythmicity.

Cry2 helps coordinate the timing of muscle fiber fusion after injury. It ensures that cells don't exit the cell cycle too early and maintains the expression of genes needed for fibers to merge. Disruption of this clock component can lead to incomplete regeneration.

Acupuncture acts as a multi-targeted therapy for obesity by modulating the neuro-endocrine-immune interplay, specifically by regulating hypothalamic neuropeptides (increasing POMC/alpha-MSH, decreasing NPY/AgRP), improving leptin sensitivity, and reducing chronic low-grade inflammation.

If standard diet and exercise efforts are stalled by biological barriers like leptin resistance or chronic inflammation, acupuncture may serve as a complementary multi-targeted therapy. It works by regulating appetite hormones and reducing inflammation. However, because techniques and acupoints vary widely, consistency and professional guidance are key.

Prescription medication-driven weight loss (mdWL) using GLP-1 agonists causes facial aesthetic changes including skin laxity, hollowed cheeks, and pronounced wrinkles, primarily affecting superficial and deep fat pads rather than bone or muscle.

If you are losing weight rapidly with prescription medications like Ozempic or Wegovy, expect changes in your face, such as sagging skin or hollow cheeks, due to fat loss in specific facial layers. This is a common side effect of the medication's mechanism, not a sign of poor health. To manage this, consult an aesthetic provider about timing treatments (like fillers or skin tightening) to coincide with your weight stabilization, rather than during active rapid loss. Avoid terms like 'Ozempic face' and focus on 'mdWL' management to reduce stigma.

Injectable antiresorptive drugs (zoledronate, denosumab, romosozumab) are superior to oral bisphosphonates for preventing bone loss in long-duration space missions because they bypass gastrointestinal side effects and offer potent, sustained suppression of bone resorption.

For long-duration space travel, injectable bone-preserving drugs (zoledronate, denosumab, romosozumab) are preferred over oral options due to better efficacy and lack of gastrointestinal side effects. These drugs suppress bone resorption effectively with rare side effects when used for short durations (1-2 years).

Muscle wasting in space is primarily driven by depressed protein synthesis rather than excessive protein breakdown, and anabolic steroids are ineffective without concurrent resistance exercise.

To prevent muscle loss in space, resistance exercise is essential. Anabolic steroids may help but are weak alone and only effective when combined with strength training. The primary countermeasure remains physical exercise.

Extrusion cooking of wholegrain pearl millet promotes the formation of amylose-lipid complexes (ALCs) that moderate the release of reducing sugars and slow starch digestion compared to native or cooked native flour.

If you eat pearl millet, choosing extruded wholegrain flour and preparing it with warm (not boiling) water can help slow down how quickly your body digests the starch. This processing method creates complexes that moderate sugar release, potentially offering better metabolic control than traditional cooked porridge.

Time-restricted eating (TRE) with a maximum 10-hour daily eating window is feasible for adherence during the second and third trimesters of pregnancy in individuals at increased risk of gestational diabetes, but it does not improve glycemic control or cardiometabolic outcomes compared to usual care.

If you are pregnant and at risk for gestational diabetes, trying a 10-hour eating window (e.g., 9 AM to 7 PM) for 5 weeks is safe and feasible, but do not expect it to lower your blood sugar or weight. You may feel hungrier in the evenings, but you can still adhere to the schedule. Consult your doctor before starting.

High-protein diets (>1.6-2.2 g/kg body weight) and excessive protein supplementation may negatively alter gut microbiota by increasing toxic metabolites (ammonia, amines) through proteolytic fermentation, potentially reducing probiotic strains.

If you are a strength athlete consuming high protein (>2g/kg), monitor your gut health. Excessive protein can lead to toxic byproducts like ammonia. Consider mixing protein sources (e.g., adding soy or plant proteins) and ensuring adequate fiber intake to support probiotic bacteria and reduce gut stress.

Initial skeletal muscle size (leg fat-free mass or quadriceps cross-sectional area) does not predict the magnitude of muscle atrophy following 14 days of unilateral lower limb immobilization in men.

If you are injured and must immobilize a limb, do not assume that having larger muscles will cause you to lose them faster than a smaller person would. The rate of muscle loss during short-term immobilization (14 days) is not determined by your starting muscle size. Focus on adhering to your rehabilitation protocol and maintaining adequate protein intake.

Habitual hot-tub bathing (≥4 times/week) is associated with statistically significant, albeit small, improvements in glycemic control (HbA1c), body mass index (BMI), and diastolic blood pressure in patients with Type 2 Diabetes Mellitus.

If you have Type 2 Diabetes, taking a hot tub bath at least four times a week for about 16 minutes is associated with slightly better blood sugar control, lower body weight, and lower diastolic blood pressure. This is not a replacement for medication, but a supportive lifestyle habit. Be cautious if you are elderly or have existing heart conditions, and consult your doctor before starting.

Utilizing lipid panels (specifically triglycerides and LDL-C levels) serves as a valid clinical indicator for assessing insulin resistance.

Monitor lipid panels, particularly triglycerides and LDL-C, as they are strong indicators of insulin resistance. High HDL-C is associated with increased insulin sensitivity.

Combining protein supplementation with exercise does not provide a robust benefit for bone mineral content (BMC) or density (BMD) in middle-aged and older adults compared to exercise or protein alone.

If your goal is bone health, focus on consistent resistance or weight-bearing exercise and adequate protein intake separately. Adding extra protein supplements on top of your exercise routine does not currently show evidence of providing additional bone density benefits compared to doing just one of those things alone.

Primary care providers' lack of familiarity with anti-obesity medications (AOMs) and concerns about drug safety are primary barriers to prescribing pharmacotherapy for obesity.

If you are a provider, your hesitation to prescribe weight loss medication due to 'safety concerns' or 'lack of familiarity' is a major barrier to patient care. The paper suggests that increased familiarity with newer, highly effective AOMs (like semaglutide) and updated training can overcome these barriers. You should prioritize updating your knowledge on current pharmacotherapy guidelines to ensure patients receive evidence-based treatment.

Social determinants of health, specifically poverty and food insecurity, are significant contributors to the high prevalence of obesity in communities of color.

For individuals in communities of color, obesity rates are heavily influenced by systemic factors like poverty and food insecurity. Addressing these social determinants is crucial for effective obesity management, alongside individual lifestyle changes.

Dietary interventions (caloric restriction, high-fat, high protein-to-carbohydrate ratios, and specific micronutrients) administered during critical developmental windows (puberty, pregnancy, or lifetime) can induce transgenerational epigenetic modifications that protect offspring against environmental toxins.

To potentially protect future generations from environmental toxins, parents should consider adopting protective dietary patterns—such as high protein-to-carbohydrate ratios, caloric restriction, or specific micronutrient supplementation—during critical life stages like puberty, pregnancy, or throughout their lifetime. These dietary choices can induce epigenetic changes that may persist for multiple generations.

Epigenetic priming via nutrient deprivation (caloric restriction) in the F0 generation increases the epigenetic plasticity of subsequent generations, allowing them to better adapt to varying diets and metabolic challenges.

Moderate caloric restriction (e.g., 50-70% of normal intake) during early development or pregnancy may 'prime' the epigenome, making offspring more metabolically resilient to future dietary challenges. However, extreme restriction should be avoided as it can lead to growth issues.

In asymptomatic adults, the presence of food-specific IgG antibodies (particularly mild-to-moderate positivity) is associated with a lower prevalence of overweight, hypertriglyceridemia, and abnormal fasting blood glucose compared to IgG-negative individuals.

If you are asymptomatic and undergo routine health checks, having food-specific IgG antibodies (especially mild-to-moderate levels) is common and may actually be associated with healthier metabolic profiles (lower risk of high triglycerides, high blood sugar, and overweight). Do not interpret a positive IgG test as a diagnosis of food intolerance or allergy without clinical symptoms; it may simply reflect immune tolerance.